There are 2949 resources available
123P - The prognostic role of lymphocyte count for treatment response in immune checkpoint inhibitor therapy
Presenter: Michael Conroy
Session: E-Poster Display
Resources:
Abstract
124P - Serum parameters as prognostic biomarkers for anti PD-1/PD-L1 therapy in patients with solid tumours: A retrospective data analysis
Presenter: Christoph Minichsdorfer
Session: E-Poster Display
Resources:
Abstract
125P - Association of tumour CD4 positive lymphocytes with prognosis in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor
Presenter: Yan-juan Zhu
Session: E-Poster Display
Resources:
Abstract
126P - Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
Presenter: Neel Nissen
Session: E-Poster Display
Resources:
Abstract
127P - Personalizing treatment in colorectal cancer by monitoring bevacizumab blood levels and ICAM-1 polymorphisms
Presenter: Apostolos Papachristos
Session: E-Poster Display
Resources:
Abstract
128P - Exploratory analysis of the prognostic value of rotational thromboelastometry in colorectal cancer
Presenter: Anna Koumarianou
Session: E-Poster Display
Resources:
Abstract
129P - Comprehensive analysis of DNA damage repair deficiency across 10,613 pan-cancer patients: Implications for drug development and therapy
Presenter: Wenzhuan Xie
Session: E-Poster Display
Resources:
Abstract
130P - PTCH1 Genomic Alterations (GA) in human malignancies: A pangenomic study
Presenter: Jeffrey Ross
Session: E-Poster Display
Resources:
Abstract
131P - NTRK1/2/3 fusions in secretory versus non-secretory breast cancers
Presenter: Timothy Wilson
Session: E-Poster Display
Resources:
Abstract
132P - TRKing PTC patients: NTRK gene fusion frequency and clinical characteristics of a Finnish papillary thyroid cancer cohort
Presenter: Wei Zhang
Session: E-Poster Display
Resources:
Abstract